Total Payments
$12,180
2024 Payments
$983.06
Companies
67
Transactions
781
Medicare Patients
4,422
Medicare Billing
$702,271
Payment Breakdown by Category
Food & Beverage$12,046 (98.9%)
Education$134.76 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,046 | 777 | 98.9% |
| Education | $134.76 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,435 | 86 | $0 (2024) |
| Amgen Inc. | $962.20 | 81 | $0 (2024) |
| GlaxoSmithKline, LLC. | $541.53 | 41 | $0 (2024) |
| Lilly USA, LLC | $532.93 | 33 | $0 (2023) |
| Philips Electronics North America Corporation | $522.08 | 33 | $0 (2023) |
| GENZYME CORPORATION | $491.15 | 35 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $464.29 | 34 | $0 (2021) |
| Mylan Specialty L.P. | $454.40 | 34 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $450.62 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $396.47 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $983.06 | 56 | Regeneron Healthcare Solutions, Inc. ($155.03) |
| 2023 | $1,470 | 95 | GENZYME CORPORATION ($209.64) |
| 2022 | $1,798 | 112 | Amgen Inc. ($277.39) |
| 2021 | $2,235 | 150 | AstraZeneca Pharmaceuticals LP ($277.43) |
| 2020 | $1,791 | 114 | Sunovion Pharmaceuticals Inc. ($240.77) |
| 2019 | $1,396 | 97 | Philips Electronics North America Corporation ($193.80) |
| 2018 | $870.81 | 65 | AstraZeneca Pharmaceuticals LP ($171.76) |
| 2017 | $1,637 | 92 | AstraZeneca Pharmaceuticals LP ($224.93) |
All Payment Transactions
781 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Analgesic | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: HFCWO | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $77.78 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Analgesic | ||||||
| 08/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 948 | 2,636 | $380,647 | $180,125 |
| 2022 | 12 | 1,096 | 2,835 | $400,168 | $184,172 |
| 2021 | 13 | 1,119 | 2,531 | $344,316 | $171,795 |
| 2020 | 14 | 1,259 | 2,395 | $339,770 | $166,178 |
Total Patients
4,422
Total Services
10,397
Medicare Billing
$702,271
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 214 | 978 | $144,744 | $60,217 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 248 | 660 | $65,120 | $43,496 | 66.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 112 | 594 | $87,912 | $33,478 | 38.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 120 | 141 | $49,497 | $20,779 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $11,778 | $11,537 | 98.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 39 | 47 | $16,497 | $6,988 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,711 | $1,981 | 73.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $1,803 | $1,332 | 73.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 106 | 107 | $584.75 | $318.75 | 54.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 234 | 936 | $138,528 | $53,041 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 296 | 758 | $76,605 | $48,163 | 62.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 103 | 644 | $95,312 | $33,918 | 35.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 115 | 137 | $48,610 | $18,209 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 120 | 120 | $17,431 | $17,320 | 99.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 25 | 32 | $11,417 | $4,220 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,104 | $2,339 | 75.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $2,638 | $2,128 | 80.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $2,247 | $1,729 | 77.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 22 | $1,824 | $1,273 | 69.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $840.15 | $823.35 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $840.00 | $487.35 | 58.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 91 | 94 | $518.78 | $354.39 | 68.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $253.60 | $166.01 | 65.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 314 | 797 | $79,984 | $56,067 | 70.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 173 | 718 | $106,043 | $42,189 | 39.8% |
About Dr. Donald Huston, D.O
Dr. Donald Huston, D.O is a Pulmonary Disease healthcare provider based in Glassboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316973563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Huston, D.O has received a total of $12,180 in payments from pharmaceutical and medical device companies, with $983.06 received in 2024. These payments were reported across 781 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($12,046).
As a Medicare-enrolled provider, Huston has provided services to 4,422 Medicare beneficiaries, totaling 10,397 services with total Medicare billing of $702,271. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Glassboro, NJ
- Active Since 06/22/2006
- Last Updated 08/14/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1316973563
Products in Payments
- DUPIXENT (Biological) $928.69
- Yupelri (Drug) $454.40
- SYMBICORT (Drug) $448.03
- ACTHAR (Biological) $414.08
- Repatha (Biological) $382.17
- Otezla (Drug) $323.00
- The Vest System Model 105 Home Care (Device) $321.58
- TRELEGY ELLIPTA (Drug) $282.01
- (8874) inCourage (Device) $276.45
- XARELTO (Drug) $255.95
- ENTRESTO (Drug) $250.76
- Vascepa (Drug) $245.15
- FASENRA (Biological) $229.37
- APTIOM (Drug) $229.14
- FARXIGA (Drug) $227.43
- NEXLETOL (Drug) $221.75
- Livalo (Drug) $217.51
- Ozempic (Drug) $214.75
- LONHALA MAGNAIR (Drug) $214.52
- SMARTVEST (Device) $199.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.